181,95 €
181,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
91 °P sammeln
181,95 €
181,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
91 °P sammeln
Als Download kaufen
181,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
91 °P sammeln
Jetzt verschenken
181,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
91 °P sammeln
  • Format: ePub

Demonstrating the benefits of reperfusion therapy, this volume examines fibrinolytic agents that can be used alone or in combination with other care regimens to improve the benefits of reperfusion therapy and reduce the risks of treatment. It summarizes the use of percutaneous coronary intervention (PCI) across the spectrum of reperfusion therapy, helping specialists identify barriers to the early treatment of patients in various practice environments. The book also reviews the clinical relevance and implications of recent clinical trials and the integration of these findings into the current practice of acute reperfusion therapy.…mehr

Produktbeschreibung
Demonstrating the benefits of reperfusion therapy, this volume examines fibrinolytic agents that can be used alone or in combination with other care regimens to improve the benefits of reperfusion therapy and reduce the risks of treatment. It summarizes the use of percutaneous coronary intervention (PCI) across the spectrum of reperfusion therapy, helping specialists identify barriers to the early treatment of patients in various practice environments. The book also reviews the clinical relevance and implications of recent clinical trials and the integration of these findings into the current practice of acute reperfusion therapy.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
ERIC R. BATES is Professor of Internal Medicine at the University of Michigan. Dr. Bates received his M.D. from the University of Michigan Medical School, Ann Arbor, and trained in internal medicine and cardiology at the University of Michigan Hospitals. His major clinical interests include acute myocardial infarction, acute coronary syndromes, and coronary artery disease. His research efforts have focused on fibrinolytic and catheter-based reperfusion therapy for acute myocardial infarction and cardiogenic shock, antiplatelet and anticoagulant therapy for coronary thrombosis, and coronary artery revascularization. Dr. Bates has served on the steering committees for several important international multicenter randomized clinical trials. He serves on the editorial boards of the American Journal of Cardiology, the European Journal of Cardiology, the Journal of the American College of Cardiology, the American Heart Journal, Catheterization and Cardiovascular Interventions, and Cardiology News. Dr. Bates is a member of the ACC/AHA writing committee to update the 1999 guidelines for acute myocardial infarction. He is also a member of the American Board of Internal Medicine Interventional Cardiology Test Committee.